Enzo Biochem Inc. ($0.01 Par Value)

2.00-0.0100-0.50%Vol 587.98K1Y Perf -36.99%
Jun 28th, 2022 16:00 DELAYED
BID1.98 ASK2.06
Open2.01 Previous Close2.01
Pre-Market- After-Market2.00
 - -  - -%
Target Price
12.00 
Analyst Rating
— 0.00
Potential %
500.00 
Finscreener Ranking
★★★★★     64.44
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★+     54.34
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★     52.50
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
0.00 
Earnings Rating
Buy
Market Cap97.44M 
Earnings Date
9th Jun 2022
Alpha-0.02 Standard Deviation0.13
Beta0.81 

Today's Price Range

1.982.06

52W Range

2.004.15

5 Year PE Ratio Range

-100.90121.30

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-10.27%
1 Month
-11.06%
3 Months
-32.78%
6 Months
-36.79%
1 Year
-36.99%
3 Years
-40.36%
5 Years
-82.31%
10 Years
18.24%

TickerPriceChg.Chg.%
ENZ2.00-0.0100-0.50
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
1.70
2.50
0.21
0.33
-
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
42.50
-4.40
-1.80
-8.20
-6.17
RevenueValueIndustryS&P 500US Markets
111.60M
2.29
12.73
0.45
Earnings HistoryEstimateReportedSurprise %
Q03 2022--0.09-
Q02 2022-0.03-
Q01 2022--0.04-
Q03 2021-0.04-
Q02 2021-0.09-
Q01 2021-0.01-
Q04 2020--0.07-
Q03 2020--0.17-
Earnings Per EndEstimateRevision %Trend
1/2018 QR-0.010.00-
4/2018 QR0.00--
7/2018 FY-0.02--
7/2018 FY-0.030.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume587.98K
Shares Outstanding48.72K
Shares Float36.01M
Trades Count1.56K
Dollar Volume1.19M
Avg. Volume82.23K
Avg. Weekly Volume106.76K
Avg. Monthly Volume76.49K
Avg. Quarterly Volume63.45K

Enzo Biochem Inc. ($0.01 Par Value) (NYSE: ENZ) stock closed at 2.01 per share at the end of the most recent trading day (a -3.83% change compared to the prior day closing price) with a volume of 220.18K shares and market capitalization of 97.44M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 448 people. Enzo Biochem Inc. ($0.01 Par Value) CEO is Elazar Rabbani.

The one-year performance of Enzo Biochem Inc. ($0.01 Par Value) stock is -36.99%, while year-to-date (YTD) performance is -37.38%. ENZ stock has a five-year performance of -82.31%. Its 52-week range is between 2 and 4.15, which gives ENZ stock a 52-week price range ratio of 0.00%

Enzo Biochem Inc. ($0.01 Par Value) currently has a PE ratio of -14.90, a price-to-book (PB) ratio of 1.64, a price-to-sale (PS) ratio of 0.88, a price to cashflow ratio of 397.10, a PEG ratio of 2.32, a ROA of -6.44%, a ROC of -7.40% and a ROE of -11.01%. The company’s profit margin is -6.17%, its EBITDA margin is -1.80%, and its revenue ttm is $111.60 Million , which makes it $2.29 revenue per share.

Of the last four earnings reports from Enzo Biochem Inc. ($0.01 Par Value), there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Enzo Biochem Inc. ($0.01 Par Value)’s next earnings report date is -.

The consensus rating of Wall Street analysts for Enzo Biochem Inc. ($0.01 Par Value) is (0), with a target price of $12, which is +500.00% compared to the current price. The earnings rating for Enzo Biochem Inc. ($0.01 Par Value) stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Enzo Biochem Inc. ($0.01 Par Value) has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Enzo Biochem Inc. ($0.01 Par Value) has a Sell technical analysis rating based on Technical Indicators (ADX : 13.74, ATR14 : 0.14, CCI20 : -175.40, Chaikin Money Flow : -0.23, MACD : -0.09, Money Flow Index : 31.40, ROC : -16.60, RSI : 35.50, STOCH (14,3) : 2.00, STOCH RSI : 0.00, UO : 35.58, Williams %R : -98.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Enzo Biochem Inc. ($0.01 Par Value) in the last 12-months were: Bradley L. Radoff (Buy at a value of $275 500), David Bench (Buy at a value of $7 525)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Strong Buy
1.00

Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

CEO: Elazar Rabbani

Telephone: +1 212 583-0100

Address: 527 Madison Avenue, New York 10022, NY, US

Number of employees: 448

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

Bearish Bullish

54%46%

News

Stocktwits